- Home
- GLPG vs MCRI Comparison
GLPG vs MCRI Comparison
Compare GLPG & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- MCRI
- Stock Information
- Founded
- GLPG 1999
- MCRI 1972
- Country
- GLPG Belgium
- MCRI United States
- Employees
- GLPG N/A
- MCRI N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- MCRI Hotels/Resorts
- Sector
- GLPG Health Care
- MCRI Consumer Discretionary
- Exchange
- GLPG Nasdaq
- MCRI Nasdaq
- Market Cap
- GLPG 1.8B
- MCRI 1.5B
- IPO Year
- GLPG 2005
- MCRI 1993
- Fundamental
- Price
- GLPG $27.73
- MCRI $84.44
- Analyst Decision
- GLPG Sell
- MCRI Hold
- Analyst Count
- GLPG 4
- MCRI 5
- Target Price
- GLPG $25.33
- MCRI $88.60
- AVG Volume (30 Days)
- GLPG 432.0K
- MCRI 89.4K
- Earning Date
- GLPG 07-31-2025
- MCRI 07-23-2025
- Dividend Yield
- GLPG N/A
- MCRI 1.42%
- EPS Growth
- GLPG N/A
- MCRI N/A
- EPS
- GLPG N/A
- MCRI 3.96
- Revenue
- GLPG $311,493,731.00
- MCRI $525,923,000.00
- Revenue This Year
- GLPG $0.78
- MCRI $4.32
- Revenue Next Year
- GLPG N/A
- MCRI $2.41
- P/E Ratio
- GLPG N/A
- MCRI $21.31
- Revenue Growth
- GLPG 18.32
- MCRI 3.84
- 52 Week Low
- GLPG $22.36
- MCRI $65.65
- 52 Week High
- GLPG $31.23
- MCRI $96.11
- Technical
- Relative Strength Index (RSI)
- GLPG 50.32
- MCRI 61.73
- Support Level
- GLPG $28.57
- MCRI $83.13
- Resistance Level
- GLPG $29.41
- MCRI $85.28
- Average True Range (ATR)
- GLPG 0.52
- MCRI 1.57
- MACD
- GLPG -0.16
- MCRI 0.02
- Stochastic Oscillator
- GLPG 9.33
- MCRI 82.79
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.